1. Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)

   • Lucy Gao
   • Arielle Medford
   • Jeffrey Peppercorn

   Review 15 February 2024 Pages: 211 - 226

   

2. Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

   • Kerstin Wimmer
   • Dominik Hlauschek
   • Florian Fitzal

   Clinical trial Open access 25 January 2024 Pages: 227 - 239

   

3. The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy

   • Raz Mutai
   • Iryna Kuchuk
   • Hadar Goldvaser

   Clinical trial Open access 12 February 2024 Pages: 241 - 248

   

4. Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer

   • Ying Chen
   • John C. Markowitz
   • David J. Hellerstein

   Clinical trial 20 February 2024 Pages: 249 - 256

   

5. A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes

   • Thomas M. Campbell
   • Erin K. Campbell
   • Luke J. Peppone

   Clinical trial Open access 06 March 2024 Pages: 257 - 266

   

6. Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial

   • Angeline Ginzac
   • Ioana Molnar
   • Marie-Ange Mouret-Reynier

   Clinical trial Open access 07 March 2024 Pages: 267 - 279

   

7. Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience

   • Hila Bufman
   • Renata Faermann
   • Miri Sklair-Levy

   Epidemiology Open access 21 February 2024 Pages: 281 - 285

8. Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry

   • Sandra M. E. Geurts
   • Khava I. E. Ibragimova
   • Vivianne C. G. Tjan-Heijnen

   Epidemiology Open access 21 February 2024 Pages: 287 - 302

   

9. Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery

   • Sohayb Faleh
   • Ipshita Prakash
   • Stephanie M. Wong

   Epidemiology 21 February 2024 Pages: 303 - 312

   

10. Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk

    • Madelon M. Voets
    • Noa S. Hassink
    • Sabine Siesling

    Epidemiology Open access 26 February 2024 Pages: 313 - 322

    

11. Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme

    • Vaitheeswaran Kulothungan
    • Thilagavathi Ramamoorthy
    • Prashant Mathur

    Epidemiology Open access 04 March 2024 Pages: 323 - 332

    

12. Survival among patients with untreated metastatic breast cancer: “What if I do nothing?”

    • Jennifer K. Plichta
    • Samantha M. Thomas
    • E. Shelley Hwang

    Epidemiology 05 March 2024 Pages: 333 - 347

    

13. Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study

    • R Charles Coombes
    • Christina Angelou
    • Carlo Palmieri

    Original Laboratory Investigation Open access 20 January 2024 Pages: 349 - 358

    

14. Development of a core outcome set for breast cancer-related lymphedema: a Delphi study

    • David Doubblestein
    • Linda Koehler
    • Jane Armer

    Original Laboratory Investigation Open access 29 February 2024 Pages: 359 - 370

    

15. Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration

    • Yang Wu
    • Zheqi Li
    • Bin Luo

    Original Laboratory Investigation 01 March 2024 Pages: 371 - 386

    

16. Primary MALT lymphoma of the breast: pathological and radiological characteristics

    • Yukiko Shibahara
    • Jan M. A. Delabie
    • Susan J. Done

    Original Laboratory Investigation 01 March 2024 Pages: 387 - 394

    

17. Pro-vegetarian dietary pattern and risk of breast cancer: a case–control study

    • Yasaman Hosseini
    • Pegah Hadi Sichani
    • Bahram Rashidkhani

    RESEARCH 28 February 2024 Pages: 395 - 402

18. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis

    • Hongxia Sun
    • Eun Young Kang
    • Aysegul A. Sahin

    Research 05 March 2024 Pages: 403 - 411

    

19. Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study

    • Kai Finsterbusch
    • Paul J. van Diest
    • Cornelia M. Focke

    Research 07 March 2024 Pages: 413 - 421

    

20. Reassessing treatment strategies for DCIS: analysis of survival and recurrence patterns

    • Kefah Mokbel
    • Munaser Alamoodi

    Letter to the Editor 15 February 2024 Pages: 423 - 424